Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia

por Muselli, Fabien, Mourgues, Lucas, Rochet, Nathalie, Nebout, Marielle, Guerci, Agnès, Verhoeyen, Els, Krug, Adrien, Legros, Laurence, Peyron, Jean-François, Mary, Didier
Publicado 2023

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

por Gentil, Melanie, Hugues, Patricia, Desterke, Christophe, Telliam, Gladys, Sloma, Ivan, Souza, Lucas E. B., Baykal, Seda, Artus, Jerome, Griscelli, Frank, Guerci, Agnes, Johnson-Ansah, Hyacinthe, Foudi, Adlen, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Publicado 2018

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34(−) and immature CD34(+) cells

por Berger, Marc G., Lebecque, Benjamin, Tassin, Thomas, Dannus, Louis-Thomas, Berger, Juliette, Soucal, Mélanie, Guerci, Agnès, Cony-Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Guyotat, Denis, Gagnieu, Marie-Claude, Pereira, Bruno, Saugues, Sandrine, Tournilhac, Olivier, Hermet, Eric, Bourgne, Céline
Publicado 2021